[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341774-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341774-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","hif1a-as2-promotes-the-metabolic-reprogramming-and-progression-of-colorectal-cancer-via-mir-141-3pfoxc1-axis","HIF1A-AS2 promotes the metabolic reprogramming and progression of colorectal cancer via miR-141-3p/FOXC1 axis","","HIF1A-AS2 can regulate tumorigenesis in colorectal cancer (CRC), yet its detailed molecular basis was unclear. Using RNA-sequencing, RT-qPCR, and FISH, researchers identified that HIF1A-AS2 is upregulated in CRC tissues and links to poor prognosis. Functional studies showed HIF1A-AS2 enhances CRC proliferation, metastasis, and aerobic glycolysis. Mechanistically, HIF1A-AS2 increases FOXC1 by sponging miR-141-3p, while SP1 transcriptionally activates HIF1A-AS2. Exosomal delivery of HIF1A-AS2 further promotes malignancy in recipient cells, supporting its diagnostic and therapeutic potential via the miR-141-3p/FOXC1 axis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/hif1a-as2-promotes-the-metabolic-reprogramming-and-progression-of-colorectal-cancer-via-mir-141-3pfoxc1-axis/341774/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/hif1a-as2-promotes-the-metabolic-reprogramming-and-progression-of-colorectal-cancer-via-mir-141-3pfoxc1-axis/341774.png","ImageObject",300,407,{"name":42,"@type":43},"Levi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What evidence shows HIF1A-AS2 is involved in colorectal cancer progression?","Question",{"text":63,"@type":64},"RNA-sequencing, RT-qPCR, and FISH showed HIF1A-AS2 is upregulated in CRC tissues and associated with poor prognosis. Functional experiments further indicated it promotes proliferation, metastasis, and aerobic glycolysis of CRC cells.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does HIF1A-AS2 mechanistically regulate FOXC1 expression?",{"text":68,"@type":64},"HIF1A-AS2 promotes FOXC1 expression by sponging miR-141-3p. SP1 is described as a transcriptional activator of HIF1A-AS2.",{"name":70,"@type":61,"acceptedAnswer":71},"What role do exosomes play in the effects of HIF1A-AS2?",{"text":72,"@type":64},"HIF1A-AS2 can be packaged into exosomes and delivered to recipient tumor cells, where it promotes a malignant phenotype, strengthening its impact on CRC progression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341774,1790195669,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nHIF1A-AS2 promotes the metabolic reprogramming and progression of colorectal cancer via miR-141-3p/FOXC1 axis  \nXinyang Zhong1,2,11, Yaxian Wang1,2,11, Xuefeng He3,11, Xinxin He4,11, Zijuan Hu2,5,6,7, Huixia Huang2,5,6,7, Jiayu Chen 1,2, Keji Chen2,5,6,7, Ping Wei 2,5,6,7, Senlin Zhao 1,2, Yilin Wang2,8 ✉, Hong Zhang9 ✉, Bo Feng 10 ✉ and Dawei Li 1,2 ✉  \n© The Author(s) 2024  \n\n|  | lncRNA can regulate tumorigenesis development and distant metastasis of colorectal cancer (CRC) . However, the detailed molecular mechanisms are still largely unknown. Using RNA-sequencing data, RT-qPCR, and FISH assay, we found that HIF1A-AS2 was upregulated in CRC tissues and associated with poor prognosis. Functional experiments were performed to determine the roles of HIF1A-AS2 in tumor progression and we found that HIF1A-AS2 can promote the proliferation, metastasis, and aerobic glycolysis of CRC cells. Mechanistically, HIF1A-AS2 can promote FOXC1 expression by sponging miR-141-3p. SP1 can transcriptionally activate HIF1A-AS2 . Further, HIF1A-AS2 can be packaged into exosomes and promote the malignant phenotype of recipient tumor cells. Taken together, we discovered that SP1-induced HIF1A-AS2 can promote the metabolic reprogramming and progression of CRC via |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| miR-141-3p/FOXC1 axis. HIF1A-AS2 is a promising diagnostic marker and treatment target in CRC. |  |  |\n|  | Cell Death and Disease (2024)15:645; [https://doi.org/10.1038/s41419-024-06958-2](https://doi.org/10.1038/s41419-024-06958-2) |  |\n|  |  |  |\n\nINTRODUCTION  \nIn 2022, colorectal cancer (CRC) remains the second leading cause of cancer-related deaths and the third most commonly diagnosed tumor, imposing a signiﬁcant economic and social burden on many countries [1] . Despite various treatment options, such as surgery resection, chemotherapy, targeted therapy, and immune therapy, a considerable number of patients experience disease progression. Thus, investigating the pathogenesis and discovering effective therapeutic targets in CRC is critical.  \nMetabolic reprogramming is a hallmark of cancer [2] . One of the most widely recognized metabolic characteristics of carcinoma cells is the Warburg effect, which refers to the capability to metabolize substantial amounts of glucose to produce lactate, regardless of the availability of oxygen, hence also termed aerobic glycolysis [3, 4] . Aerobic glycolysis can alter the extracellular tumor microenvironment (TME), satisfy the energetic and biosynthetic needs of cancer cells, and maintain the redox homeostasis of tumor cells [5] . Tumor cells absorb signiﬁcant amounts of glucose and release lactate, which promotes tumor growth and leads to a heterogeneous TME characterized by extracellular acidosis, hypoxia, and nutrition deprivation [3] . On the one hand, the abnormal TME can impair the function of immune cells; on the other hand, it can activate the transcriptional factors orthe signaling pathways in CRC in an abnormal manner [6, 7] . We summarized the oncogenic roles of the Warburg effect in CRC and  \nsuggested that targeting this metabolic feature has great potential in CRC therapy [8] .  \nRecently, the emerging functions of long non-coding RNAs (lncRNAs) in tumor biology have got much attention. Besides their ability to regulate transcription and chromatin/histone remodeling, lncRNAs act as miRNA sponges and protein scaffolds, modify mRNA and protein stability, and play a signiﬁcant role in cancer metabolism [9, 10] . Notably, our previous research suggested that lncRNA MIR17HG is abnormally upregulated in CRC and promotes colorectal cancer liver metastasis (CRLM) via upregulating the expression of HK1, a key enzyme in glycolysis [7] . Moreover, lncRNAs can be packaged into exosomes and exported into the tumor microenvironment to inﬂuence the biological behavior of nearby cells [11] . Add","cbCaimSAKLFc9apW","https://ap.wps.com/l/cbCaimSAKLFc9apW","pdf",10710632,18,"English","# Introduction\n## Metabolic reprogramming and the Warburg effect in CRC\n## Long non-coding RNAs and exosome-mediated tumor regulation\n## Rationale for studying HIF1A-AS2 in CRC","[{\"question\":\"What evidence shows HIF1A-AS2 is involved in colorectal cancer progression?\",\"answer\":\"RNA-sequencing, RT-qPCR, and FISH showed HIF1A-AS2 is upregulated in CRC tissues and associated with poor prognosis. Functional experiments further indicated it promotes proliferation, metastasis, and aerobic glycolysis of CRC cells.\"},{\"question\":\"How does HIF1A-AS2 mechanistically regulate FOXC1 expression?\",\"answer\":\"HIF1A-AS2 promotes FOXC1 expression by sponging miR-141-3p. SP1 is described as a transcriptional activator of HIF1A-AS2.\"},{\"question\":\"What role do exosomes play in the effects of HIF1A-AS2?\",\"answer\":\"HIF1A-AS2 can be packaged into exosomes and delivered to recipient tumor cells, where it promotes a malignant phenotype, strengthening its impact on CRC progression.\"}]","HIF1A-AS2 promotes the metabolic reprogramming and progression of colorectal cancer via miR-141-3p/FOXC1 axis | PDF",1790043744,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ef8be64308840fff9367234aec43db18.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c83f8805c320d70e458dd63726c1144e.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a34a97327353b2bcc840f9872fb8c05c.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/65793f6010d7ff005ccb473b53a1e08a.webp",980,1301]